Matches in Wikidata for { <http://www.wikidata.org/entity/Q61308274> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q61308274 description "article scientifique publié en 2016" @default.
- Q61308274 description "im Oktober 2016 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61308274 description "wetenschappelijk artikel" @default.
- Q61308274 description "наукова стаття, опублікована в жовтні 2016" @default.
- Q61308274 name "A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib" @default.
- Q61308274 name "A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib" @default.
- Q61308274 type Item @default.
- Q61308274 label "A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib" @default.
- Q61308274 label "A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib" @default.
- Q61308274 prefLabel "A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib" @default.
- Q61308274 prefLabel "A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib" @default.
- Q61308274 P1433 Q61308274-48BCBA45-5D5C-42B8-B1E4-3171A06BF668 @default.
- Q61308274 P1476 Q61308274-E4DACBC1-E8D9-4450-BE5D-C9236684D89E @default.
- Q61308274 P2093 Q61308274-374DFE4A-11E6-4BDB-BEC7-F6FD99FD06A7 @default.
- Q61308274 P2093 Q61308274-3AAEE09E-98F0-41CF-94E5-87CA0B412B62 @default.
- Q61308274 P2093 Q61308274-67A6CB77-566E-438F-ACAC-A7158EEB53B1 @default.
- Q61308274 P2093 Q61308274-71091CA0-83FD-4A51-B41E-F9E868496B9D @default.
- Q61308274 P2093 Q61308274-88E448F7-4F53-4946-8132-62841189B06D @default.
- Q61308274 P2093 Q61308274-8CF1413B-57BB-48F2-9912-E213EA21EDF1 @default.
- Q61308274 P2093 Q61308274-9BCD9062-9FD0-4681-8615-58F5E223326D @default.
- Q61308274 P2093 Q61308274-9D17DBC3-134A-407C-A048-D4E5DDB41D9C @default.
- Q61308274 P2093 Q61308274-A55B3AD9-81A6-4CC3-A2A9-1BDD6A70C260 @default.
- Q61308274 P2093 Q61308274-AA86A819-B070-41C2-B2A9-62275932D761 @default.
- Q61308274 P2093 Q61308274-B1ADA407-7120-432A-9C47-1F1F06DB4236 @default.
- Q61308274 P2093 Q61308274-B6A718EA-1093-4185-92FE-7F86FDD3AE17 @default.
- Q61308274 P2093 Q61308274-C6CC77BD-1440-446D-9ACD-78B7E06AFAD0 @default.
- Q61308274 P2093 Q61308274-D72F34FB-A7A0-4A6E-9A43-9B2FD65D3396 @default.
- Q61308274 P2093 Q61308274-E211C0C0-6C1B-43F1-BCAA-AE72E23C56AB @default.
- Q61308274 P2093 Q61308274-E92035E8-D67C-42CE-BF23-2DABBD6CE05D @default.
- Q61308274 P2093 Q61308274-EC17B83B-4263-43D4-84F4-55E0B5EA47A0 @default.
- Q61308274 P2093 Q61308274-F5AD07DB-E618-45B2-BDF2-467409A5C696 @default.
- Q61308274 P2093 Q61308274-F7E56FCD-6ED6-4B0B-B94A-2F67A9F8999C @default.
- Q61308274 P2093 Q61308274-FB3A06DD-A504-457F-9960-A91A45CDF4E2 @default.
- Q61308274 P31 Q61308274-361EC8C3-3BDF-4B26-BDCA-320D30D0CFA0 @default.
- Q61308274 P356 Q61308274-CADB2931-C605-4653-83E5-04CE87E49E69 @default.
- Q61308274 P433 Q61308274-4B6C088D-777B-40AC-9B45-DEE1F0957386 @default.
- Q61308274 P478 Q61308274-4C17FB81-278B-4CAF-9C23-242E98BA6CB2 @default.
- Q61308274 P577 Q61308274-41CE5B84-0C1D-468A-AE4E-110F46742DE4 @default.
- Q61308274 P921 Q61308274-5F3B3E80-6BBE-476F-9B56-C001153B2CE0 @default.
- Q61308274 P921 Q61308274-C1175A8E-4362-4182-9A38-130FE9D5DBC5 @default.
- Q61308274 P356 MDW435.17 @default.
- Q61308274 P1433 Q326122 @default.
- Q61308274 P1476 "A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib" @default.
- Q61308274 P2093 "A. Wotherspoon" @default.
- Q61308274 P2093 "C. Robb" @default.
- Q61308274 P2093 "D. Alderson" @default.
- Q61308274 P2093 "D. Cunningham" @default.
- Q61308274 P2093 "E. Smyth" @default.
- Q61308274 P2093 "H. Grabsch" @default.
- Q61308274 P2093 "J. Blazeby" @default.
- Q61308274 P2093 "J. Thompson" @default.
- Q61308274 P2093 "K. Sumpter" @default.
- Q61308274 P2093 "M. Griffin" @default.
- Q61308274 P2093 "M. Seymour" @default.
- Q61308274 P2093 "R. Langley" @default.
- Q61308274 P2093 "R. Mason" @default.
- Q61308274 P2093 "S. Darby" @default.
- Q61308274 P2093 "S. Rowley" @default.
- Q61308274 P2093 "S. Sothi" @default.
- Q61308274 P2093 "S. Stenning" @default.
- Q61308274 P2093 "T. Crosby" @default.
- Q61308274 P2093 "W. Allum" @default.
- Q61308274 P2093 "W. Mansoor" @default.
- Q61308274 P31 Q13442814 @default.
- Q61308274 P356 "10.1093/ANNONC/MDW435.17" @default.
- Q61308274 P433 "suppl_6" @default.
- Q61308274 P478 "27" @default.
- Q61308274 P577 "2016-10-01T00:00:00Z" @default.
- Q61308274 P921 Q356033 @default.
- Q61308274 P921 Q420207 @default.